Sankala Group
BBH icon

Sankala Group’s VanEck Biotech ETF BBH Stock Holding History

Sankala Group’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$20.7K Hold
84
– – 0.01% 316
2026
Q2 		$19K Buy
84
+17
+25% +$3.2K 0.01% 344
2026
Q1 		$12.3K Sell
67
-19
-22% -$3.66K 0.01% 352
2025
Q4 		$17K Buy
+86
New +$15.9K 0.01% 329

Other funds holding BBH

LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Conservest Capital Advisors
Conservest Capital Advisors Wynnewood, Pennsylvania $1.28B AUM 17.34% 1-Year Est. Return
Paragon Private Wealth Management
Paragon Private Wealth Management Lexington, Kentucky $326M AUM 26.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
L.J. Altfest & Co
L.J. Altfest & Co New York $1.01B AUM 24.77% 1-Year Est. Return
Institute for Wealth Management
Institute for Wealth Management Denver, Colorado $1.13B AUM 31.46% 1-Year Est. Return
Wealthfront Advisers
Wealthfront Advisers Palo Alto, California $52.7B AUM 16.5% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Sankala Group's BBH Position: Q3 2026 in Review

Sankala Group held its VanEck Biotech ETF (BBH) position steady in Q3 2026 at 84 shares worth $20.7K. The position accounts for 0.01% of the portfolio, ranked #316.

Sankala Group first reported a position in BBH in Q4 2025 and has held it in 4 quarters since. 66 funds tracked by Wall St. Rank hold BBH as of Q3 2026.

  • Sankala Group held 84 shares of VanEck Biotech ETF worth $20.7K as of Q3 2026.
  • Sankala Group left its VanEck Biotech ETF share count unchanged in Q3 2026.
  • VanEck Biotech ETF made up 0.01% of Sankala Group's portfolio in Q3 2026, its #316 holding.
  • Sankala Group first reported a position in VanEck Biotech ETF in Q4 2025 and has held it in 4 quarters since.
  • 66 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2026.

Based on Sankala Group's 13F filing for Q3 2026, filed 9 Nov 2026.